Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Host obesity alters the ovarian tumor immune microenvironment and impacts response to standard of care chemotherapy

Fig. 1

Experimental overview. Female mice were fed a control low fat diet (LFD) or a high fat diet (HFD) until a ~ 10 g difference in weight was attained prior to injection with murine ovarian cancer cells (ID8-Trp53−/−, W0). After three weeks (W3), mice were injected with weight-adjusted standard of care chemotherapy (paclitaxel and cisplatin; PC) twice weekly for a total of 6 or 9 cycles as indicated (red arrowheads). Dissection and quantitation of tumor burden occurred one week following cessation of chemotherapy (W7 or W9). Figure created with Biorender.com

Back to article page